Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalized from a heart ...
Behavioral and Cognitive Improvement: By acting on brain regions related to appetite and addiction, these drugs not only ...
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalized from a heart attack or heart failure, regardless of their body mass index, according to new ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Researchers said weight-loss drugs could affect health in eye-opening ways, but other experts say more work needs to be done ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.
Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...